Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.

Slides:



Advertisements
Similar presentations
Investigating Gender Differences in HEDIS Measures Related to Heart Disease Ann F. Chou, PhD, MPH Carol S. Weisman, PhD Rosaly Correa-de-Araujo, MD, PhD.
Advertisements

Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
National Service Frameworks Dr Stephen Newell February 2002.
CMS Core Measures Evidence-Based Performance Measurement.
Professor Abdus Samad MD FACC Karachi Institute of Heart Diseases Karachi, Pakistan May 1, 2010.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Research with clinical populations: Cardiac rehabilitation Shawn N Fraser University of Alberta.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Orlando, Florida – October 7, 2011 Cardiac Rehab: Improving Outcomes One Step at a Time Martha Gulati MD, MS, FACC, FAHA Associate Professor of Medicine.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
Rivka Herman 1 *,RN. M.Sc Michal Libergal 1 *, PhD; David Rott 2, MD Michal Libergal 1 *, PhD; David Rott 2, MD 1 Henrietta Szold Hadassah-Hebrew University.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation? July
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
New guidelines for CABG
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
Management of Stable Angina SIGN 96
Fenofibrate Intervention and Event Lowering in Diabetes FIELDFIELD Presented at The American Heart Association Scientific Sessions, November 2005 Presented.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Secondary Prevention Following Coronary Artery Bypass Grafting: are we Compliant with the Guidelines? V. Joshi, B. Bridgewater University Hospital of South.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
BARI 2D Trial BARI 2D Trial Presented at the American Diabetes Association (ADA) Annual Scientific Sessions 2009 in New Orleans The Bypass Angioplasty.
Secondary Prevention & Cardiac Rehabilitation Malcolm Walker Consultant Cardiologist UCLH & the Heart Hospital, London.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Arterial Revascularization Therapies Part II: a non- randomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with.
Tarunjit Singh Department of Internal Medicine Westchester Medical Center New York Medical College Valhalla NY.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
AA-2-1 Jerome D. Cohen, MD, FACC, FACP Professor of Internal Medicine / Cardiology Director, Preventive Cardiology Programs St. Louis University Health.
Clinical Trial Results. org SAGE Trial Prakash Deedwania, MD; Peter H. Stone, MD; C. Noel Bairey Merz, MD; Juan Cosin-Aguilar, MD; Nevres Koylan, MD; Don.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial PEACE Trial Presented at The American Heart Association Scientific Sessions.
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
Medical Management of Claudication: Just Walk it Off!!
Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.
? What more will it take to turn the tide of treatment for angina patients from a PCI-first to an optimal medical therapy– first approach? 1.
Risk Factor Modification in CCR. How does CR work?
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Management Strategies for Post-Intervention in Patients with CAD VBWG.
© Continuing Medical Implementation ® …...bridging the care gap Geriovascular Prevention Optimizing Prevention of Cardiovascular Disease in the Elderly.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
An analysis of 22,672 patients from the CLARIFY registry
Total Occlusion Study of Canada (TOSCA-2) Trial
Cardiac Rehabilitation Part I
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Successful CTO PCI Associated with Lower Mortality Risk
The Anglo Scandinavian Cardiac Outcomes Trial
RAAS Blockade: Focus on ACEI
The following slides highlight a discussion and analysis of presentations in the Late-Breaking Clinical Trials session from the 55th Annual Scientific.
Nursing Management: Patients With Coronary Vascular Disorders
Section 5: Intervention and drug therapy
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
Prevention & the Healthcare Crisis 2004
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Global Registry of Acute Coronary Events: GRACE
LRC-CPPT and MRFIT Content Points:
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Cardiovascular Epidemiology and Epidemiological Modelling
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and Yakima Valley Memorial Hospitals

Rehabilitation To restore to good health or useful life, through therapy and education. Changing our own behavior, for better health

Changing Behavior Resistances Therapy: connotation of ‘mental illness’ Rehabilitation: connotation of ‘substance abuse’ Personal Responsibility is much more difficult than blaming No one can rehabilitate another; most of the work is done by the patient, for himself..

Active versus Passive Second Person versus First Person It is easier to tell others how they should change, than to change ourselves: empathy

Cardiac Rehabilitation 2011 Bill of Fare 1.What is cardiac rehabilitation? 2.What is the difference between primary and secondary prevention? 3.Is there good clinical evidence which supports the efficacy of cardiac rehabilitation? –Survival –Myocardial infarct (MI) reduction –Stroke (CVA) prevention –Avoidance of subsequent bypass surgery (CABG) –Reduced repeat stenting (PCI) –Reduced frequency of hospitalization

Cardiac Rehabilitation 2011 Bill of Fare (2) 4. Does the evidence, which supports the use of cardiac rehabilitation apply: –In the ‘reperfusion-era’ of post MI care? –To the elderly (Medicare population)? –Women? –Care-givers, themselves? 5. In your personal, and professional experience, is behavior change: –Easy, i.e. a ‘slam-dunk’? –Impossible, and therefore, not even worth discussing –Possible, but requiring sustained effort

Definition of Cardiac Rehabilitation A multi-component intervention, which is designed to: Optimize a cardiac patient's physical, psychological and social function, and Stabilize, slow, or even reverse the underlying atherosclerosis; thereby Reducing the morbidity and mortality of coronary artery disease (CAD).

Physical Activity and the Prevention of Coronary Heart Disease Meta-analysis of 43 studies from world literature of physical activity and CAD up to 1987 Objective assessments of individual activity, and of CHD Attempt to infer causal relationship based on criteria of AB Hill and Rothman –Sequence: activity precedes incidence of CHD –Consistency across studies –Strength of association –Graded across multiple levels of activity –Plausibility –Coherence –Supported by biological studies Powell et al; Ann Rev Public Health1987;8:253

Diet, Exercise, and Smoking Modification after acute coronary syndrome (ACS) 18,809 patients from OASIS 5 prospective randomized trial, conducted in 41 countries. Most patient were compliant with aspirin (96%); statins (79%); ACE-I/beta blockers (72%). 29% did not follow diet or exercise; 1/3 of smokers persisted; 42% did either diet or exercise; 30% did both diet and exercise. MI risk reduced significantly by diet, exercise and smoking cessation. Circulation 2010;121:

Cardiac Rehabilitation: Contemporary Era and Elderly Population 601,099 Medicare beneficiaries, who were hospitalized for coronary conditions and/or revascularization (PCI or CABG) year mortalities examined using multiple statistical methods Only 12% used cardiac rehabilitation services; they averaged 24 sessions. Mortality rates were 21-34% lower among users of cardiac rehabilitation Dose-response noted: more is better.

Performance Measures for Primary Prevention 1.Risk factor screening 2.Dietary counseling 3.Physical activity counseling 4.Smoking assessment 5.Smoking cessation intervention 6.Weight/adiposity assessment 7.Weight management 8.Blood pressure measurement 9.Blood pressure control 10.Lipid measurement 11.Lipid control 12.Global risk assessment 13.Aspirin use Circulation 2009;120:

Core Components of Cardiac Rehabilitation/ Secondary Prevention Evaluation –Patient assessment –Nutritional –Weight management –Blood pressure –Lipids –Diabetes –Smoking –Psychosocial –Physical Activity –Exercise training Intervention

Cardiac Rehabilitation 2011: Summary (1) Neither coronary bypass graft surgery (CABG), nor percutaneous coronary intervention (PCI), with or without stents, have been shown, in stable patients, to prevent heart attacks.

Cardiac Rehabilitation 2011: Summary (2) Lipid lowering (primarily with statin drugs such as Lipitor, Crestor, or Zocor); Aspirin; Beta-blockers; and ACE-inhibition; have all been shown to reduce the risk of future myocardial infarction (MI), among post MI patients, and patients with stable coronary disease. Compliance can be enhanced with the educational component of cardiac rehabilitation.

Cardiac Rehabilitation 2011: Summary (3) Diet, exercise, and smoking cessation have been shown to reduce the risk of subsequent heart attack. Cardiac rehabilitation, in a large, Medicare study, has been sown to be associated with reduced likelihood of heart attack. Getting people to take personal responsibility for their own health involves behavior modification. It is not easy, but we can all do it, one step at-a-time.

‘When we study biology, we are life, contemplating its nature.’ George Wald, PhD In the catheterization lab, or echo lab, or exercise lab, or pulmonary function lab, We are contemplating life’s nature And we are applying the fruits of our contemplations to the care of our fellow human. We follow the same biological principles.

Care-Giver, Heal Thyself